Phase I Study of Ombrabulin, a Vascular Disrupting Agent (VDA), Administered Every 3 Weeks to Japanese Patients with Advanced Solid Tumors
2012 ◽
Vol 23
◽
pp. xi110
T. Kurata
◽
H. Murakami
◽
Y. Fujisaka
◽
H. Kiyota
◽
H. Hayashi
◽
...
Takayasu Kurata
◽
Haruyasu Murakami
◽
Yasuhito Fujisaka
◽
Hidemi Kiyota
◽
Kazuhiko Nakagawa
◽
...
2011 ◽
Vol 68
(4)
◽
pp. 959-970
◽
Alejandro D. Ricart
◽
Edward A. Ashton
◽
Matthew M. Cooney
◽
John Sarantopoulos
◽
Joanna M. Brell
◽
...
2016 ◽
Vol 48
(1)
◽
pp. 28-36
◽
Do-Youn Oh
◽
Tae-Min Kim
◽
Sae-Won Han
◽
Dong-Yeop Shin
◽
Yun Gyoo Lee
◽
...
2010 ◽
Vol 8
(7)
◽
pp. 122-123
◽
J.C. Soria
◽
R. Bahleda
◽
B. Besse
◽
C. Sessa
◽
R.g. Calderone
◽
...
2014 ◽
Vol 73
(3)
◽
pp. 623-630
◽
H. Murakami
◽
T. Kurata
◽
Y. Onozawa
◽
J. Watanabe
◽
A. Ono
◽
...
2015 ◽
Vol 75
(6)
◽
pp. 1155-1161
◽
Satoru Kitazono
◽
Yutaka Fujiwara
◽
Shinji Nakamichi
◽
Hidenori Mizugaki
◽
Hiroshi Nokihara
◽
...
2013 ◽
Vol 19
(17)
◽
pp. 4832-4842
◽
Cristiana Sessa
◽
Patricia Lorusso
◽
Anthony Tolcher
◽
Françoise Farace
◽
Nathalie Lassau
◽
...
2012 ◽
Vol 23
◽
pp. xi110
S. Takahashi
◽
T. Ura
◽
K. Nakano
◽
K. Chin
◽
M. Yokoyama
◽
...
Koichiro Watanabe
◽
Hironobu Minami
◽
Satoshi Otsu
◽
Yoshinori Hirashima
◽
Ryotaro Morinaga
◽
...
2017 ◽
Vol 109
(1)
◽
pp. 193-198
◽
Toshihiko Doi
◽
Becker Hewes
◽
Tomoyuki Kakizume
◽
Takeshi Tajima
◽
Norifumi Ishikawa
◽
...